Appearances

• Panel Discussion
• Panel Discussion
• Transition to How to Succeed in Grants
• Transition to Faculty
• Transition to Careers for People who don't like to write Grants
• Panel Discussion A
• Panel Discussion
• Panel Q & A
• Panel Discussion
• Panel Discussion
• Panel Discussion
• Open Discussion
• Open Discussion
• Medical Student Awardee Presentations
• Panel Discussion
• Q & A Discussion
• Q & A Discussion
• Intermission
• Q & A Discussion
• Panel Discussion
• Q & A Discussion
• Panel Discussion
• Q & A Discussion
• Q & A Discussion
• Discussion
• Discussion
• Panel Discussion
• Q & A Discussion
• Discussion
• Discussion
• Panel Discussion
• Discussion
• Q & A Discussion
• Q & A Discussion
• Rebuttals 1
• Discussion 1
• Rebuttals 2
• Discussion 2
• Panel Discussion
• Q & A Discussion
• Q & A Discussion
• Discussion
• Q & A Discussion
• Discussion
• Panel Discussion
• Panel Discussion
• Discussion
• Closing Remarks
• Q & A Discussion
• Q & A Discussion
• Panel Discussion
• Discussion
• Discussion
• Q & A Discussion 1
• Q & A Discussion 2
• Q & A Discussion 3
• Q & A Discussion 4
• Discussion
• Q & A Discussion
• Panel Discussion
• Panel Discussion
• Q & A Discussion
• Discussion
• Q & A Discussion
• Discussion
• Q & A Discussion
• Panel Discussion
• Discussion
• Panel Discussion
• Discussion 5
• Discussion 1
• Discussion 2
• Discussion 3
• Discussion 4
• Discussion
• Q & A Discussion
• Q & A Discussion
• Panel Discussion
• Discussion
• Q & A Discussion
• Q & A Discussion
• Q & A Discussion
• Discussion
• Discussion
• Opening Remarks
• Discussion: POCUS Cases
• Q & A Discussion
• Q & A Discussion
• Panel Discussion
• Discussion - Improving Adherence to Medications Using Pharmacogenetics
• Discussion - Intervention Approaches to Improve Cardiovascular Medication Adherence
• Discussion - Motivational Interviewing Counseling for Health Behavior Change to Promote Physical Activity in Older Women
• Discussion - Comparison of Technology-Based Approaches to Measuring Self-Care Outcomes
• Discussion - Nutrition Guidelines and Medical Nutrition Therapy
• Discussion - Dietary Insufficiencies, Micronutrients, and Drug-Nutrient Interactions
• Discussion - Dietary Patterns, Sources of Nutrients, and Safety Concerns
• Discussion - Mobile Solutions to Improve Adherence to Medications
• Discussion
• Opening Remarks
• Q & A Discussion
• Q & A Discussion
• Discussion
• Q & A Discussion 2
• Q & A Discussion
• Q & A Discussion
• Opening Remarks
• Q & A Discussion
• Closing Remarks
• Q & A Discussion - The Most Important Outcomes Research Studies in Heart Failure of the Past Year
• Q & A Discussion - The Most Important Outcomes Research Studies in Interventional Cardiology of the Past Year
• Q & A Discussion - The Most Important Outcomes Research Studies in Electrophysiology of the Past Year
• Q & A Discussion - The Most Important Cardiovascular Health Policy Studies of the Past Year
• Panel Disussion
• Q & A Discussion
• Q & A Discussion
• Panel Discussion
• Panelist Discussion 1
• Panelist Discussion 2
• Q & A Discussion
• Q & A Discussion
• Q & A Discussion
• Discussion
• Discussion
• Q & A Discussion
• Q & A Discussion - Mechanistic Relationships Between Arrhythmias and Cardiomyopathy: What Have We Learned?
• Q & A Discussion - Management of Atrial Fibrillation in Advanced Heart Failure
• Q & A Discussion - Management of Arrhythmias in Inflammatory Cardiomyopathies
• Moderated Discussion
• Q & A Discussion - Implementation of an E-health Tool in Heart Failure Clinics in Primary Care
• Q & A Discussion - The Role of Symptoms in Adherence to mHealth ECG Monitoring for Atrial Fibrillation
• Q & A Discussion - Medication Adherence Mediates the Relationship Between Memory and Emergency Room and Hospital Utilization in Patients With Heart Failure
• Q & A Discussion - A Novel ECG Only Method Identifies Obstructive Sleep Apnea in Acute Coronary Syndrome Patients
• Q & A Discussion
• Q & A Discussion
• Q & A Discussion
• Q & A Discussion
• Discussion
• Q & A Discussion
• Opening Remarks
• Closing Remarks
• ARS & Discussion - P-ulmonary Atresia/MAPCA's: Case Presentation
• Surgical Conference with the Experts: How Do We Repair it Today? What Will Drive Future Improvements?
• Cardiovascular Nursing Clinical Symposium: Day One
• Atherosclerosis Research Update (AHA/Chinese Society of Cardiology Joint Session)
• Tackling the Burden of Coronary Artery Disease in Bangladesh: Prospects and Barriers (AHA/National Heart Foundation of Bangladesh Joint Session)
• Trending Topics in Basic Science
• State of the Art Cardiovascular Care 2017
• The Pendulum of Biomarkers for Heart Failure: Which way will it swing?
• The Real World: ACS Management from Around the Globe
• Advances in Nuclear Cardiology
• Contemporary Management of Mechanical Complications Post-MI
• How Should I Manage Patients with HFpEF?
• Is More Data Better: Role of Electronic Data on Clinical Care
• Rapid Fire Review of Coronary CT: State-of-the-Art in 2017
• State of the Art in Management of Aortic Grafts
• Disruptive Solutions (Part 1): Artificial Intelligence
• Measuring Quality after PCI: Right Patient, Right Procedure, Right Outcome?
• Redefining Diagnosis & Treatment of Pediatric Hypertension: The 5th Report on BP in Youth
• Therapeutic Decisions in NSTE-ACS Special Patients Groups
• When Guidelines Fall Short - What To Do?
• Disruptive Solutions (Part 2): Sensors and Diagnostics
• Controversies in Coronary Revascularization
• Pulmonary vs. Systemic Hypertension: Insights into Vascular Remodeling
• Using Genomics to Improve Outcomes in Congenital Heart Disease
• Circadian Rhythms in Cardiovascular Disease and Hypertension
• Clinical Application of High Sensitivity Troponin Results: Confounders, Guided Therapy, Rapid Rule Out and Lab Challenges
• Rapid Fire 21st Century Innovations in Pediatric Cardiovascular Care
• Difficult Decisions in Heart Transplantation
• From Dusk till Dawn: A real-time case-based evolution of acute PE to CTEPH
• Critical Cardiogenic Shock (INTERMACS 1): Bringing Patients Back From the Brink
• HDAC Inhibition and Epigenetics in Cardiopulmonary Disease
• Vascular Medicine Clinical Workshop: Evaluation of the Swollen Leg
• Sometimes it is a Zebra: Less Common Cardiomyopathies
• Thrombotic versus Non-Thrombotic Myocardial Infarction
• Innovative Imaging in the Diagnosis and Treatment of Heart Failure
• TAVR: Imaging Highlights
• Comprehensive Self-Management of Patients with CVD
• Great Debates in Medical Management: Blood Pressure Targets and PCSK9 Inhibitors
• Avoiding Failure in Heart Failure Care
• Ultrasound in the CICU: Taking it Beyond the Standard TTE
• Precision Medicine in Cardiovascular and Stroke Nursing: Part 2
• Innovations in Pediatric Cardiology
• CVRI Imaging Bootcamp
• Innovation in Cardiac Surgery: From Imaginative Research to Transformative Clinical Therapy (AHA/The Society of Thoracic Surgeons Joint Session)
• CVSA Part 3: The Surgeon Scientist is Very Much Alive
• Fogarty, NHLBI, NIH and the Future of Global Cardiovascular Health Research: Priority Research and Research Methods for Global Cardiovascular Health
• Emerging Science from the 3CPR Early Career Committee
• How I got Here: A Panel Discussion on the different types of EP Career Options
• Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease
• Innovations in Electrophysiology: How Your Life Will Be Changed
• Smooth Muscle Cell Plasticity in Atherosclerosis
• New Technologic Approaches to AF Ablation
• Immunometabolism, Inflammation, and Cardiovascular Disease
• Precision Medicine Summit: Rapid Fire Reports from the Front Lines
• Main Event: Outcomes of Cardiac Arrest Survivors With ICDs
• PVD WorkShop: Venous Thromboembolism
• PVD WorkShop: Cerebrovascular Disorders
• PVD WorkShop: Aortic Disorders
• Main Event: Prognostication After Resuscitation
• PVD WorkShop: Lower Extremity PAD
• PVD WorkShop: Pearls of Wisdom for Trainees
• Main Event: The Role of Genetics in Cardiac Arrest and Trauma
• Curing Atrial Fibrillation: Where to Next?
• Main Event: New Directions in Dispatch-Assisted CPR
• Inflammation and Immunity in the Pathophysiology of Hypertension
• Where's the Beef ? Re-Evaluating Popular Diets, Coconut Oil, Sugar and Sodium in 2017
• Main Event: Educational Innovations in Resuscitation
• Lies, Darn Lies, and Statistics: Pitfalls in Literature Interpretation and Fake News
• Main Event: Coagulopathies in Resuscitation
• 2017 Hypertension Clinical Practice Guidelines
• Treating ACS in 2017 and Beyond
• Main Event: Pharmacologic Resuscitation Therapies
• MACRA for Dummies and MIPS for Dips: Understanding and Meeting Your Quality Measures
• Racing Toward the Finish Line of Life - Too Much Exercise May Be Bad For Your Heart
• Bringing Genetics to Your Clinic (AHA/National Society of Genetic Counselors)
• The Pharma Perspective: A Fireside Chat with Folks from Industry
• Direct to Participant Research: Implementation and Implications
• RCTs in the Health Technology Era
• Traditional Clinical Trials: Advanced Topics
• CVSA Part 1: What is the future of Cardiac Surgery?
• Cardiovascular Nursing Clinical Symposium: Day Two
• Managing the Complex Cardiometabolic Patient: Interactive Case Studies
• New Trends in Heart Failure (AHA/Mexican Society of Cardiology Joint Session)
• Should We Screen for Unknown AF to Prevent Stroke? (AHA/AF-SCREEN International Collaboration Joint Session)
• Heart Failure and Comorbidities (AHA/Romanian Society of Cardiology Joint Session)
• Cardiovascular Health & Brain Resiliency: The Odd Couple or BFFs?
• DNA Damage Response and Cardio-metabolic Disease (AHA/Japanese Circulation Society Joint Session)
• Management of Valve Heart Disease in Various Clinical Settings: What We Still Need to Know (AHA/Brazilian Society of Cardiology Joint Session)
• Reducing Global Premature CVD Mortality (AHA/World Heart Federation Joint Session)
• The "Dysfunctional" Adipocyte in Cardiovascular Disease
• Visceral Adiposity and Cardiovascular Disease (AHA/International Atherosclerosis Society Joint Session)
• A Global Perspective on Transitional Care Strategies to Manage Chronic CVD Outcomes (AHA/ European Society of Cardiology Council on Cardiovascular Nursing and Allied Health Professionals Joint Session)
• Non-pharmacologic Therapy of Arrhythmias: Indications and Outcomes (AHA/Heart Rhythm Society Joint Session)
• Recent Advances in the Assessment of Omega-3 Fatty Acids & Vascular Risk
• Risky Business: Managing Risk for Patients, Yourself, and Your Organization
• Valvular Heart Disease in 2017 (AHA/Iranian Heart Association Joint Session)
• Intervention in Valvular Heart Disease (AHA/Great Wall International Congress of Cardiology Joint Session)
• Post-Translational Regulation of the Cardiac Proteome
• Selected Topics in Cardiac Valve Disease (AHA/InterAmerican Society of Cardiology Joint Session)
• Technology and Healthcare: The Road Ahead
• Can We Even Treat Obesity? Defining Optimal Strategies Across the Lifespan (AHA/The Obesity Society Joint Session)
• Imaging in Valve Disease (AHA/European Society of Cardiology Joint Session)
• Therapeutic Discovery for Heart Failure
• Concurrent Session: EMS Session: Mechanical CPR
• A New Threat to America: Tropical Heart Disease and Endocarditis (AHA/Spanish Society of Cardiology Joint Session)
• Origins of Obesity and Cardiometabolic Risk: Interplay of Genes, Environment and the Microbiome
• The Current State of Lipidomic Biomarkers for Cardiovascular Risk
• Does the Obesity Paradox in Heart Failure Really Exist?
• Evaluation and Treatment of Heart Disease in Women: How Should Care Differ?
• Target: BP™ 2017 Update and Lessons Learned from Participating Practices
• Therapeutic Strategies in the Management of Acute Coronary Syndrome (AHA/Chilean Society of Cardiology Joint Session)
• Clinical Practice Guidelines for Blood Pressure Management: Next Steps
• Advances and Controversies in the Management of ST-Elevation Myocardial Infarction (AHA/Polish Cardiac Society Joint Session)
• CVD Diseases and its Risk Factors in CIS Countries (AHA/Cardioprogress Foundation (Moscow, Russia) Joint Session)
• Advanced Technologies for Cardiovascular Investigation
• Assessment of Thromboembolic Risk in Atrial Fibrillation: Is it All That Simple? (AHA/French Society of Cardiology Joint Session)
• Heart Failure with Preserved Ejection Fraction (HFpEF) Revisited (AHA/Argentine Society of Cardiology Joint Session)
• New Horizons in Cardiac Imaging (AHA/Israel Heart Society Joint Session)
• Outcomes of PCI in Current-Generation DES Era (AHA/Korean Society of Cardiology Joint Session)
• The Latest and Greatest in Device Technology
• Diabetes and Heart Failure: Recent Perspectives
• Genetics and Molecular Mechanism of Pediatric Cardiovascular Disease (AHA/Japanese Society of Pediatric Cardiology and Cardiac Surgery Joint Session)
• Heart Team Based Management of Heart Failure (AHA/Heart and Health Foundation of Turkey Joint session)
• 2017 ACC/AHA/HRS Guideline on the Managements of Patients with Ventricular Arrhythmias and Sudden Cardiac Death
• A Fresh Look at CAD Prevention (AHA/European Society of Cardiology Joint Session)
• Microbiome, Metabolomics and Cardiovascular Risk
• Precision Medicine Summit: Improving Precision in Cardiomyopathies
• Sleep Disorders Affect Cardiometabolic Health (AHA/American Academy of Sleep Medicine Joint Session)
• Tune Up Mitochondria to Treat Cardiovascular Disease?
• Updates in Cardiovascular Diseases from Lebanon (AHA/Lebanese Society of Cardiology and Cardiac Surgery Joint Session)
• Novel Mechanisms for Interorgan Crosstalk
• One Size Doesn't Fit All-- Difficult Decisions in Prevention Practice
• The Divided States of America: Addressing Disparities in Cardiovascular Care
• Current Advances in Management of Heart Failure: From Prevention to Medication (AHA/Russian Society of Cardiology Joint Session)
• Heart Failure: From Bench to Bedside (AHA/Italian Federation of Cardiology Joint Session)
• Screening and Managing Athletes with Sudden Cardiac Death Risk
• m-Health and Monitoring of CVD Interventions and Outcomes
• Impact of Sex, Race and Aging on Cardiovascular Disease
• Arrhythmia Management in Patients with Advanced Heart Failure
• The Most Important CV Quality and Outcomes Studies for 2017
• Vascular Regeneration
• SFRN Information Session
• Early Career Opening General Session: Transitions
• ARS & Discussion - Borderline Left Ventricle: Case Presentation
• ARS & Discussion - Complex Double Switch Candidate: Case Presentation
• ARS & Discussion - Ebstein Anomaly: Case Presentation
• Class I: How to Approach Challenging Cases like an Expert
• Vascular Medicine Master Class I and II: How to Handle Challenging Cases like a Pro
• ATVB Journal Session: iPSC-Derived Cell Types Relevant to Atherothrombosis
• Biological Mechanisms of Cardiac Cell-Based Therapy
• Opening Remarks
• Clinical Management of Inherited Arrhythmias: Genes, Drugs and Devices
• Panel Discussion
• Novel Multimodality Imaging of Coronary Artery Disease
• Q&A
• Guideline Updates and the Reasons Behind Them: CAD/PVD, EP, HF, Imaging
• Frontiers in Vascular and Valvular Calcification
• Panel Participant
• Anticoagulation Therapy Should Not Be Restarted in Patients with Anticoagulation-related Lobar Intracerebral Hemorrhage (NO - REBUTTAL)